Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | 225,429 | reported | 15 Nov 2024 | tx 9+727,484−21,092 |
| Codiak BioSciences, Inc. | 190,000 | reported | 24 Jan 2023 | tx 4+490,000 |
| Advaxis, Inc. | 166,312 | reported | 31 Dec 2015 | tx 39+502,205−65,713 |
| Prelude Therapeutics Inc | 1,289 | reported | 05 Oct 2021 | tx 51+260,000−330,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Nov 2024 | TAX_WITHHOLDING | RECURSION PHARMACEUTICALS, INC. | 4,187 | 6.18 USD | |
| 15 Aug 2024 | TAX_WITHHOLDING | RECURSION PHARMACEUTICALS, INC. | 14,146 | 6.69 USD | |
| 15 May 2024 | TAX_WITHHOLDING | RECURSION PHARMACEUTICALS, INC. | 867 | 10.01 USD | |
| 09 Feb 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 49,768 | 0.00 USD | |
| 09 Feb 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 6,040 | 0.00 USD | |
| 09 Feb 2024 | TAX_WITHHOLDING | RECURSION PHARMACEUTICALS, INC. | 1,892 | 10.09 USD | |
| 09 Feb 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 99,537 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 190,713 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 381,426 | 0.00 USD | deriv |
| 24 Jan 2023 | GRANT_AWARD | Codiak BioSciences, Inc. | 190,000 | 0.00 USD | deriv |
| 16 Sept 2022 | GRANT_AWARD | Codiak BioSciences, Inc. | 80,000 | 0.00 USD | deriv |
| 02 May 2022 | GRANT_AWARD | Codiak BioSciences, Inc. | 200,000 | 0.00 USD | deriv |
| 02 May 2022 | GRANT_AWARD | Codiak BioSciences, Inc. | 20,000 | 0.00 USD | deriv |
| 05 Oct 2021 | SALE | Prelude Therapeutics Inc | 1,289 | 32.06 USD | |
| 05 Oct 2021 | SALE | Prelude Therapeutics Inc | 7,803 | 31.30 USD | |
| 05 Oct 2021 | SALE | Prelude Therapeutics Inc | 5,908 | 30.26 USD | |
| 05 Oct 2021 | EXERCISE | Prelude Therapeutics Inc | 15,000 | 1.89 USD | |
| 05 Oct 2021 | EXERCISE | Prelude Therapeutics Inc | 15,000 | 0.00 USD | deriv |
| 07 Sept 2021 | SALE | Prelude Therapeutics Inc | 2,873 | 36.92 USD | |
| 07 Sept 2021 | SALE | Prelude Therapeutics Inc | 7,487 | 35.91 USD | |
| 07 Sept 2021 | EXERCISE | Prelude Therapeutics Inc | 15,000 | 1.89 USD | |
| 07 Sept 2021 | SALE | Prelude Therapeutics Inc | 4,640 | 37.79 USD | |
| 07 Sept 2021 | EXERCISE | Prelude Therapeutics Inc | 15,000 | 0.00 USD | deriv |
| 05 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 15,000 | 1.89 USD | |
| 05 Aug 2021 | SALE | Prelude Therapeutics Inc | 6,116 | 29.93 USD |